Testing new drugs is a slow, expensive, and manual process. Artificial intelligence has the potential to disrupt every stage of the clinical trials process — from matching eligible patients to studies to monitoring adherence and data collection.

For more info see: https://www.cbinsights.com/research/clinical-trials-ai-tech-disruption/